ABOUT SIMR
Company Profile
Management Team
SAB
Vision & Mission
Milestones
Investors
R&D
Research Focus
Pipeline
Translational Center
MEDIA
Expanded Access Policy
Press Releases
PARTNER
Business Development
Research Cooperation
JOIN US
CONTACT
中文
|
EN
ABOUT SIMR
Company Profile
Management Team
SAB
Vision & Mission
Milestones
Investors
R&D
Research Focus
Pipeline
Translational Center
MEDIA
Expanded Access Policy
Press Releases
PARTNER
Business Development
Research Cooperation
JOIN US
CONTACT
中文
EN
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
Home
>
ABOUT SIMR
>
Milestones
>
2020
2020
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
September-The first patient successfully dosed with the candidate drug SR419
发布时间：2020年09月24日
The first patient successfully dosed with the candidate drug SR419 for peripheral neuropathic pain
上一篇：无
下一篇：暂无
